| Engineered K1F bacteriophages kill intracellular Escherichia coli K1 in human epithelial cells C Møller-Olsen, SFS Ho, RD Shukla, T Feher, AP Sagona Scientific reports 8 (1), 17559, 2018 | 73 | 2018 |
| Bacteriophage K1F targets Escherichia coli K1 in cerebral endothelial cells and influences the barrier function C Møller-Olsen, T Ross, KN Leppard, V Foisor, C Smith, ... Scientific reports 10 (1), 8903, 2020 | 34 | 2020 |
| Differential regulation of β2-adrenoceptor and adenosine A2B receptor signalling by GRK and arrestin proteins in arterial smooth muscle CA Nash, CP Nelson, R Mistry, C Moeller-Olsen, E Christofidou, ... Cellular Signalling 51, 86-98, 2018 | 16 | 2018 |
| Engineered K1F bacteriophages kill intracellular Escherichia coli K1 in human epithelial cells. Sci Rep 8: 17559 C Møller-Olsen, SFS Ho, RD Shukla, T Feher, AP Sagona | 8 | 2018 |
| Analysing parallel strategies to alter the host specificity of bacteriophage T7 Á Avramucz, C Møller-Olsen, AM Grigonyte, Y Paramalingam, A Millard, ... Biology 10 (6), 556, 2021 | 7 | 2021 |
| Advances in engineering of bacteriophages for therapeutic applications C Møller-Olsen, GK Dhanoa, T Fehér, AP Sagona New Frontiers and Applications of Synthetic Biology, 215-229, 2022 | | 2022 |
| Investigation of the molecular and cellular mechanisms of in vitro phage therapy in human cells and the innate immune response against Escherichia coli K1 and bacteriophage K1F C Møller-Olsen University of Warwick, 2021 | | 2021 |
| An investigation of the molecular and cellular mechanisms of in vitro phage therapy in human cells C Møller-Olsen, S Ho, T Ross, A Sagona Access Microbiology 1 (1A), 768, 2019 | | 2019 |
| Examining the effects of immune mediators on the vasculature of the blood and lymphatic systems of the human skin: IL-1β, TNFα and CpG oligodeoxynucleotides C Moeller-Olsen Masters Thesis-University of Auckland, 2016 | | 2016 |
